Pharmaloz Wins Two New Contracts in January that are Anticipated to Significantly Increase Lozenge Revenues and Profitability
Company in Late-Stage Discussions with Two Additional Large Global Brands Which, if Consummated, Could more than Triple Run-Rate of Revenues Before Year-End 2024Tuesday, January 23, 2024
Sensus Healthcare prelims
Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, today announces preliminary unaudited financial results for the three and 12 months ended December 31, 2023.
The company expects to report revenue for the fourth quarter of 2023 of more than $12 million, with full-year revenue expected to exceed $23 million.
“We are delighted to report a strong uptick in our business during the fourth quarter and to achieve our guidance to ship more than 60 SRT systems during 2023,” said Joe Sardano, chairman and chief executive officer of Sensus Healthcare. “Our customers were impacted by inflation and, to a lesser extent, interest rates during the first three quarters of 2023. Yet as anticipated, they adjusted to the economic environment as the year progressed. Further, utilization of superficial radiotherapy to treat non-melanoma skin cancer continued to increase, driven by favorable reimbursement, an aging population and clinical results that are as good, if not better than, Mohs surgery.”
Mr. Sardano added, “We expect heightened interest from prospective customers at three important trade shows during the first quarter of 2024, namely the Winter Clinical and the South Beach Symposium in February and the American Academy of Dermatology annual meeting in March. Sensus will have a strong presence at these conferences and will be demonstrating our SRT systems and other products and services.”
Fed Should Stop Quantitative Tightening, Reduce Interest Rates Soon: Bill Gross
- Fed cuts should come in next 6 to 12 months: Pimco co-founder
- US policymakers next meet Jan. 31 to discuss interest rates
Bill Gross has some advice for the Federal Reserve: stop winding down its balance sheet now, and start cutting interest rates in coming months to avoid recession.
“I would stop quantitative tightening,” the co-founder and former chief investment officer of Pacific Investment Management Co. said on Bloomberg Television when asked what he would do differently if he were leading the Fed. “That is just not a correct philosophy and policy at this point in time to continue to tighten quantitatively.”
Theratechnologies: FDA continues to review file past PDUFA date
Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, has received correspondence from the U.S. Food and Drug Administration (FDA) regarding the Company’s supplemental Biologics License Application (sBLA) for the F8 formulation of tesamorelin. The FDA has notified the Company that it is continuing its review of the application beyond the Prescription Drug User Fee Act (PDUFA) goal date of January 22, 2024. Further information will be provided in due course.
Ensysce Breakthrough Therapy Designation Granted for PF614-MPAR overdose protection
Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ:ENSC), a clinical-stage company applying transformative chemistry to improve prescription drug safety, today announced receipt of notice from the U.S Food and Drug Administration (FDA) that it has granted Breakthrough Therapy Designation (BTD) for PF614-MPAR. A next generation opioid, PF614-MPAR represents a major scientific innovation, as it is what we believe to be the first product with oral overdose protection in any drug class.
BTD is a rarely used designation, having been granted to fewer than 300 drugs. It is designed to expedite the development and review of drugs that are intended to treat a serious condition where preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over available therapies.
Monday, January 22, 2024
Evotec says it promptly reported share trades withheld by former CEO
German biotech firm Evotec on Monday said it had immediately reported trades in its shares by its former CEO as soon as it was informed of the transactions that he had kept under wraps for up to three years.
"Evotec has acted always in compliance with the statutory regulations and our own very strict compliance code," supervisory board Chair Iris Loew Friedrich said in an analyst call.
She added that the former CEO had "clearly" not been in compliance with the company's established procedures.
Evotec, which works in drug development with partners including Novo Nordisk, Bayer and Bristol-Myers Squibb, said on Jan. 3 that CEO Werner Lanthaler would resign for personal reasons after almost 15 years with the company.
According to Reuters calculations based on regulatory filings, Lanthaler had purchased Evotec shares for about 4.8 million euros ($5.23 million) between 2021 and 2023, while selling shares for a total of 7 million euros.
German insider trading regulation gives executives three days to report share trades involving their company.
https://finance.yahoo.com/news/1-evotec-says-promptly-reported-152637841.html
France's farmer lobby turns up heat on government, says protests to continue
French farmers will continue to protest pending government action, union representatives told reporters after a meeting with Prime Minister Gabriel Attal and Farming Minister Marc Fesneau to address the reasons for the demonstrations.
"We told him (Attal) we wouldn't settle for words," Arnaud Rousseau, head of FNSEA, France's largest farm union, told reporters after the meeting. "We told (him) that, to build confidence, he needed to go into the field. He committed to meeting farmers in the field in the coming days"
Fesneau said the first proclamations for farmers would be presented this week, French news broadcast television BFM TV reported.
Farmers in France are protesting over price pressures, taxes, and green regulation - grievances shared by farmers across Europe.
Farmers blocked roads in parts of France last week in action similar to widespread protests by farmers in Germany.
They cite a government tax on tractor fuel, cheap imports, water storage issues, price pressures from retailers and government red tape among their grievances.
President Emmanuel Macron is wary of farmers' growing support for the far right ahead of the European Parliament elections in June. The government has put a draft farming law on hold, saying it wanted to hear from farming representatives first to include additional measures to support the sector.
FARMERS SAY LIVELIHOODS UNDER THREAT
Farming policy has always been a sensitive issue in France, the European Union's biggest agricultural producer, with thousands of independent producers of wine, meat and dairy. Farmers have a track record of disruptive protests.
Jordan Bardella, president of Marine Le Pen's far-right Rassemblement National, travelled to the western Gironde region to voice support for farmers and France's agricultural heritage.
"Farmers are part of our identity and I refuse to let them die," Bardella told reporters on Saturday.
Many farmers say their livelihoods are threatened as food retailers step up pressure to bring down prices after a run of high inflation.
Fearing a spillover from farmer protests in Germany, Poland, and Romania, the government withdrew a draft farming law planned for debate this week and invited farming representatives for talks.
Arnaud Gaillot, head of the Young Farmers(Jeunes Agriculteurs), and Rousseau said they would seek assurances from Attal and Fesneau that a special law aimed at keeping farming revenues stable would be better enforced.
Gaillot also called for a regulatory pause, saying bureaucracy was eating up too much of farmers' time and that regulations aimed at cutting carbon emissions were "too much."
"I think we could be on the eve of a big farmers' movement if there are no answers. Our European neighbours, with whom we are in touch, are calling us," he added.
Fesneau told newspaper Midi Libre on Monday that the draft law would remain tabled during the first half of this year, after amendments including measures to cut red tape.
The minister visited an irrigation storage project in the western Vendee department on Monday and said the government had listened to farmers' calls to ease restrictions on water use, a controversial issue as water becomes scarce in summer.
"This is also to show that we are working on things, even though this may seem like it's taking a long time. ... There certainly is a need to speed up processes," he told reporters.
https://news.yahoo.com/frances-farmer-lobby-turns-heat-094021720.html
Subscribe to:
Posts (Atom)